We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
RETRACTED: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
- Abstract
This article discusses the clinical manifestations, diagnosis, severity, treatment, and outcomes of peg-asparaginase-associated pancreatitis (AAP) in pediatric patients undergoing chemotherapy. The study found that AAP is a common complication in patients with asparaginase-treated acute lymphoblastic leukemia (ALL), with abdominal pain being the most common symptom. The severity of AAP varies, and treatment involves fasting, nutritional support, and fluid resuscitation. The study emphasizes the importance of early recognition and management of AAP to improve patient outcomes. Additionally, the article suggests the need for further research to determine risk factors and establish standardized approaches for pediatric AAP.
- Subjects
CHILD patients; MEDICAL personnel; PANCREATITIS; CHRONIC pancreatitis; NECROTIZING pancreatitis; HEALTH facilities; TERMINATION of treatment
- Publication
Frontiers in Oncology, 2024, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2020.538779